Pharmaceutical composition for treating a metabolic syndrome
PK201100035A0Undetermined Publication Date: 2011-02-07SANOFI AVENTIS SA
0 Cites 0 Cited by
Patent Information
- Application Number
- PK201100035
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2011-01-19
- Publication Date
- 2011-02-07
Abstract
The invention is directed to a pharmaceutical composition containing at least one FGF-21 (fibroblast growth factor 21) compound, at least one GLP-1R (glucagon-like peptide-1 receptor) agonist and optionally at least one anti-diabetic drug and / or at least one DPP-4 (dipeptidyl peptidase-4) inhibitor for the treatment of at least one metabolic syndrome and / or atherosclerosis, in particular diabetes, dyslipidemia, obesity and / or adipositas.
Need to check novelty before this filing date? Find Prior Art